Amy Werremeyer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Amy Werremeyer

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

The Mental Health Clinician|November 23, 2020

Impact of pharmacists on outcomes for patients with psychiatric or neurologic disordersAmy Werremeyer, Jolene Bostwick, Carla Cobb, et al.

Journal of the American Pharmacists Association : Japha|July 4, 2024

Implementation of a North Dakota opioid misuse and overdose prevention program in West VirginiaElizabeth Skoy, Rebecca Linger, Heidi Eukel, et al.

Psychiatric Services (Washington, D.C.)|May 4, 2021

The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient OutcomesLisa W Goldstone, Bethany A DiPaula, Amy Werremeyer, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

The Mental Health Clinician|November 23, 2020

Impact of pharmacists on outcomes for patients with psychiatric or neurologic disordersAmy Werremeyer, Jolene Bostwick, Carla Cobb, et al.

Journal of the American Pharmacists Association : Japha|July 4, 2024

Implementation of a North Dakota opioid misuse and overdose prevention program in West VirginiaElizabeth Skoy, Rebecca Linger, Heidi Eukel, et al.

Psychiatric Services (Washington, D.C.)|May 4, 2021

The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient OutcomesLisa W Goldstone, Bethany A DiPaula, Amy Werremeyer, et al.

Pageof 4